Critical appraisal of trastuzumab in treatment of advanced stomach cancer
Judith Meza-Junco, Heather-Jane Au, Michael B SawyerDepartment of Oncology, Cross Cancer Institute, Edmonton, Alberta, CanadaAbstract: Advanced or metastatic gastric cancer constitutes the majority of patients in clinical practice. In North America, about 70% of cases are advanced or metastatic when...
Main Authors: | Judith Meza-Junco, Heather-Jane Au, Michael B Sawyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-03-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/critical-appraisal-of-trastuzumab-in-treatment-of-advanced-stomach-can-a6545 |
Similar Items
-
Trastuzumab for the treatment of HER2- positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
by: G Norman, et al.
Published: (2011-05-01) -
Critical appraisal of cabazitaxel in the management of advanced prostate cancer
by: Sumanta Kumar Pal, et al.
Published: (2010-12-01) -
Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma
by: Aguiar-Bujanda D, et al.
Published: (2015-10-01) -
Critical appraisal of bevacizumab in the treatment of ovarian cancer
by: Yoshida H, et al.
Published: (2015-04-01) -
Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal
by: S Ward, et al.
Published: (2009-06-01)